XOMA CORPORATION

(XOMA)
  Bericht
Verzögert Nasdaq  -  22:00 01.07.2022
20.84 USD   -6.46%
02.06.Kuros erhält durch Checkmate-Übernahme Meilensteinzahlung von 5 Mio USD
AW
02.06.Kuros erhält 5 Millionen Dollar Meilensteinzahlung aus der Akquisition von Checkmate durch Regeneron
MT
05.05.XOMA Corporation meldet Ergebnis für das erste Quartal bis zum 31. März 2022
CI
ÜbersichtKurseChartsNewsRatingsTermineUnternehmenFinanzenAnalystenschätzungenRevisionenDerivate 
ÜbersichtAlle NewsAnalystenempfehlungenAndere SprachenPressemitteilungenOffizielle PublikationenBranchen-NewsMarketScreener Analysen
Nachrichten in anderen Sprachen über XOMA CORPORATION
24.06.XOMA CORPORATION(NASDAQGM : XOMA) dropped from Russell 2500 Index
24.06.XOMA CORPORATION(NASDAQGM : XOMA) dropped from Russell 3000E Value Index
24.06.XOMA CORPORATION(NASDAQGM : XOMA) dropped from Russell 3000E Index
24.06.XOMA CORPORATION(NASDAQGM : XOMA) dropped from Russell 2500 Growth Index
24.06.XOMA CORPORATION(NASDAQGM : XOMA) dropped from Russell 2000 Dynamic Index
24.06.XOMA CORPORATION(NASDAQGM : XOMA) dropped from Russell 3000 Growth Index
24.06.XOMA CORPORATION(NASDAQGM : XOMA) dropped from Russell 2000 Index
24.06.XOMA CORPORATION(NASDAQGM : XOMA) dropped from Russell 2000 Growth Index
24.06.XOMA CORPORATION(NASDAQGM : XOMA) dropped from Russell Small Cap Comp Growth Index
24.06.XOMA CORPORATION(NASDAQGM : XOMA) dropped from Russell 3000 Value Index
24.06.XOMA CORPORATION(NASDAQGM : XOMA) dropped from Russell 2000 Value Index
24.06.XOMA CORPORATION(NASDAQGM : XOMA) dropped from Russell 3000E Growth Index
24.06.XOMA CORPORATION(NASDAQGM : XOMA) dropped from Russell 2000 Defensive Index
24.06.XOMA CORPORATION(NASDAQGM : XOMA) dropped from Russell 3000 Index
24.06.XOMA CORPORATION(NASDAQGM : XOMA) dropped from Russell Small Cap Completeness Index
24.06.XOMA CORPORATION(NASDAQGM : XOMA) dropped from Russell 2500 Value Index
24.06.XOMA CORPORATION(NASDAQGM : XOMA) dropped from Russell Microcap Value Index
24.06.XOMA CORPORATION(NASDAQGM : XOMA) dropped from Russell 2000 Growth-Defensive Index
24.06.XOMA CORPORATION(NASDAQGM : XOMA) dropped from Russell 2000 Value-Defensive Index
24.06.XOMA CORPORATION(NASDAQGM : XOMA) dropped from Russell Small Cap Comp Value Index
20.06.XOMA Declares Quarterly Preferred Stock Dividends
02.06.Regeneron Completes Checkmate Pharmaceuticals Deal, Triggers $5 Million Milestone Payme..
02.06.Kuros reçoit un paiement d'étapes après la cession de Checkmate
02.06.Kuros To Receive $5 Million Milestone Payment from Regeneron's Acquisition Of Checkmate
02.06.KUROS BIOSCIENCES : Completion of the Acquisition of Checkmate Pharmaceuticals by Regenero..
19.05.XOMA CORP : Change in Directors or Principal Officers, Submission of Matters to a Vote of ..
17.05.XOMA to Present at H.C. Wainwright Global Investment Conference
05.05.XOMA CORP MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF O..
05.05.XOMA Corporation Reports Earnings Results for the First Quarter Ended March 31, 2022
05.05.XOMA : Q1 Earnings Snapshot
05.05.Earnings Flash (XOMA) XOMA CORPORATION Posts Q1 Revenue $3.1M
05.05.XOMA Reports First Quarter 2022 Financial Results and Highlights Recent Operational Eve..
14.04.XOMA : 2022 Letter to Stockholders
07.04.NEXE Up 3.9% after Reporting Initial Order of XOMA Superfoods by Purity Life Health Pro..
05.04.XOMA CORP : Change in Directors or Principal Officers (form 8-K)
28.03.NEXE Innovations Brings Coffee Product Lines to Amazon Prime; Up 2%
24.03.INSIDER SELL : Xoma
21.03.XOMA Declares Quarterly Preferred Stock Dividends
16.03.Kuros Biosciences double ses revenus issus des produits en 2021
11.03.XOMA to Present at Oppenheimer's 32nd Annual Healthcare Conference
10.03.XOMA to Present at Oppenheimer's 32nd Annual Healthcare Conference
08.03.XOMA : Reports Full Year 2021 Financial Results and Highlights Recent Operational Events -..
08.03.XOMA CORP Management's Discussion and Analysis of Financial Condition and Results of O..
08.03.XOMA : Q4 Earnings Snapshot
08.03.XOMA Corporation Reports Earnings Results for the Fourth Quarter Ended December 31, 202..
08.03.XOMA Corporation Reports Earnings Results for the Full Year Ended December 31, 2021
08.03.Earnings Flash (XOMA) XOMA CORPORATION Posts Q4 Revenue $35.9M
08.03.XOMA Reports Full Year 2021 Financial Results and Highlights Recent Operational Events
01.03.NEXE Innovations Reports Retails Distribution for XOMA Superfoods Beverages
01.03.XOMA to Present at the 42nd Annual Cowen Health Care Conference
17.02.XOMA to Present at Aegis Capital Corp Investor Conference
02.02.XOMA : FDA approves Roche's Vabysmo™ for nAMD and DME
31.01.XOMA : Material Event - Form 8-K
31.01.XOMA CORP : Other Events (form 8-K)
2021XOMA Declares Quarterly Preferred Stock Dividends
2021XOMA : 2021 Year-end Letter to Shareholders
2021XOMA to Present at Upcoming Investor Conferences
2021XOMA CEO Jim Neal to Retire, Named Chairman of Board; Shares Dip Pre-Bell
2021XOMA CORP : Change in Directors or Principal Officers (form 8-K)
2021XOMA Announces Evolution of Company Leadership and Succession Planning
2021XOMA Corporation Announces Board Changes
2021XOMA Corporation Announces Resignation of Jim Neal as Chief Executive
2021NEXE Coffee and XOMA Superfoods to be Available on ECSCoffee.com
2021XOMA Earns $35 Million Milestone Payment as Anti-TGF Antibody Enters Phase 3 Clinical S..
2021XOMA : Q3 Earnings Snapshot
2021XOMA Reports Third Quarter 2021 Financial Results and Highlights Recent Operational Eve..
2021XOMA CORP : Other Events (form 8-K)
2021XOMA CORP MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF O..
2021XOMA Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended S..
2021XOMA Earns $35 Million Milestone Payment as Anti-TGFβ Antibody Enters Phase 3 Clin..
2021Xoma Corporation Earns $35 Million Milestone Payment as Anti-TGF? Antibody Enters Phase..
2021Earnings Flash (XOMA) XOMA CORPORATION Posts Q3 Revenue $0.9M
2021XOMA Reports Third Quarter 2021 Financial Results and Highlights Recent Operational Eve..
2021XOMA CORP Change in Directors or Principal Officers (form 8-K/A)
2021XOMA : Unit Signs Pact for Commercial Payment Rights to Roche's Faricimab
1  2  3  4  5  6  7Weiter